| NCT ID | NCT00549848 |
| Title | Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | no |
| Sponsors | St. Jude Children's Research Hospital |
| Indications | |
| Therapies |
Daunorubicin + Pegaspargase + Vincristine |
| Age Groups: | child |